Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Edwards Lifesciences Corp (EW)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Edwards Lifesciences's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
86.47 -1.54    -1.75%
27/04 - Closed. Currency in USD ( Disclaimer )
After Hours
86.97
+0.50
+0.58%
7:00:00 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 4,889,036
  • Bid/Ask: 85.95 / 87.02
  • Day's Range: 84.71 - 88.37
Edwards Lifesciences 86.47 -1.54 -1.75%

EW Income Statement

 
Featured here, the Income Statement (earnings report) for Edwards Lifesciences Corp, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Income Statement
Period Ending: 2024
31/03
2023
31/12
2023
30/09
2023
30/06
Total Revenue 1598.2 1534.1 1480.9 1530.2
Revenue 1598.2 1534.1 1480.9 1530.2
Other Revenue, Total - - - -
Cost of Revenue, Total 385.6 356.9 350.4 343
Gross Profit 1212.6 1177.2 1130.5 1187.2
Total Operating Expenses 1160.5 929.7 1060.3 1221
Selling/General/Admin. Expenses, Total 489.7 478.8 439.6 468.7
Research & Development 285.2 270 270.3 270.3
Depreciation / Amortization - -108.3 36.9 36.1
Interest Expense (Income) - Net Operating - -17.6 - -
Unusual Expense (Income) - - - -
Other Operating Expenses, Total - -50.1 -36.9 102.9
Operating Income 437.7 604.4 420.6 309.2
Interest Income (Expense), Net Non-Operating - - - -
Gain (Loss) on Sale of Assets - 0.2 -1.2 -3.8
Other, Net 28.3 182.5 -17.5 -25.5
Net Income Before Taxes 409.4 421.7 439.3 338.5
Provision for Income Taxes 58.4 52 55.6 33
Net Income After Taxes 351 369.7 383.7 305.5
Minority Interest 68.5 69.4 69.6 70.8
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items 351.9 369.9 384.9 307.1
Total Extraordinary Items - - - -
Net Income 351.9 369.9 384.9 307.1
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items 351.9 369.9 384.9 307.1
Dilution Adjustment 1.52 -0.482 0.915 1.95
Diluted Net Income 350.38 370.38 383.98 305.15
Diluted Weighted Average Shares 604.1 606.9 609.5 610.3
Diluted EPS Excluding Extraordinary Items 0.58 0.61 0.63 0.5
DPS - Common Stock Primary Issue - - - -
Diluted Normalized EPS 0.477 0.644 0.456 0.335
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the income statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

EW Comments

Write your thoughts about Edwards Lifesciences Corp
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email